vs

Side-by-side financial comparison of Direct Digital Holdings, Inc. (DRCT) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

Direct Digital Holdings, Inc. is the larger business by last-quarter revenue ($8.4M vs $5.5M, roughly 1.5× IMMUCELL CORP). IMMUCELL CORP runs the higher net margin — -2.5% vs -138.7%, a 136.1% gap on every dollar of revenue. On growth, Direct Digital Holdings, Inc. posted the faster year-over-year revenue change (-7.4% vs -8.4%). Over the past eight quarters, IMMUCELL CORP's revenue compounded faster (3.9% CAGR vs -38.6%).

Devolver Digital, Inc. is an American video game publisher based in Austin, Texas, specializing in the publishing of indie games. The company was founded in June 2009 by Nigel Lowrie, Harry Miller, Graeme Struthers, Rick Stults, and Mike Wilson, five executives who had been involved with Gathering of Developers and Gamecock Media Group, which published games on developer-friendly terms, but due to the high cost associated with releasing retail games saw themselves acquired and dissolved by la...

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

DRCT vs ICCC — Head-to-Head

Bigger by revenue
DRCT
DRCT
1.5× larger
DRCT
$8.4M
$5.5M
ICCC
Growing faster (revenue YoY)
DRCT
DRCT
+1.0% gap
DRCT
-7.4%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
136.1% more per $
ICCC
-2.5%
-138.7%
DRCT
Faster 2-yr revenue CAGR
ICCC
ICCC
Annualised
ICCC
3.9%
-38.6%
DRCT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DRCT
DRCT
ICCC
ICCC
Revenue
$8.4M
$5.5M
Net Profit
$-11.7M
$-139.7K
Gross Margin
26.8%
42.9%
Operating Margin
-53.4%
0.4%
Net Margin
-138.7%
-2.5%
Revenue YoY
-7.4%
-8.4%
Net Profit YoY
-434.7%
80.1%
EPS (diluted)
$-74.97
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DRCT
DRCT
ICCC
ICCC
Q4 25
$8.4M
Q3 25
$8.0M
$5.5M
Q2 25
$10.1M
$6.4M
Q1 25
$8.2M
$8.1M
Q4 24
$9.1M
$7.8M
Q3 24
$9.1M
$6.0M
Q2 24
$21.9M
$5.5M
Q1 24
$22.3M
$7.3M
Net Profit
DRCT
DRCT
ICCC
ICCC
Q4 25
$-11.7M
Q3 25
$-2.7M
$-139.7K
Q2 25
$-2.2M
$501.9K
Q1 25
$-2.4M
$1.4M
Q4 24
$-2.2M
Q3 24
$-2.7M
$-701.7K
Q2 24
$-590.0K
$-1.5M
Q1 24
$-775.0K
$-437.9K
Gross Margin
DRCT
DRCT
ICCC
ICCC
Q4 25
26.8%
Q3 25
27.7%
42.9%
Q2 25
35.1%
43.7%
Q1 25
29.3%
41.6%
Q4 24
32.5%
36.5%
Q3 24
38.7%
26.3%
Q2 24
27.1%
22.5%
Q1 24
22.4%
31.6%
Operating Margin
DRCT
DRCT
ICCC
ICCC
Q4 25
-53.4%
Q3 25
-49.0%
0.4%
Q2 25
-23.9%
8.8%
Q1 25
-48.1%
13.9%
Q4 24
-51.8%
8.0%
Q3 24
-40.3%
-9.6%
Q2 24
-9.4%
-25.3%
Q1 24
-12.6%
-4.1%
Net Margin
DRCT
DRCT
ICCC
ICCC
Q4 25
-138.7%
Q3 25
-33.6%
-2.5%
Q2 25
-22.2%
7.8%
Q1 25
-28.9%
17.9%
Q4 24
-24.0%
Q3 24
-29.6%
-11.7%
Q2 24
-2.7%
-28.0%
Q1 24
-3.5%
-6.0%
EPS (diluted)
DRCT
DRCT
ICCC
ICCC
Q4 25
$-74.97
Q3 25
$-0.24
$-0.02
Q2 25
$-0.23
$0.06
Q1 25
$-0.35
$0.16
Q4 24
$-90.17
$0.09
Q3 24
$-0.71
$-0.09
Q2 24
$-0.16
$-0.20
Q1 24
$-0.22
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DRCT
DRCT
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$728.0K
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$-7.0M
$29.8M
Total Assets
$20.2M
$45.7M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DRCT
DRCT
ICCC
ICCC
Q4 25
$728.0K
Q3 25
$871.0K
$3.9M
Q2 25
$1.6M
Q1 25
$1.8M
Q4 24
$1.4M
$3.8M
Q3 24
$4.1M
Q2 24
$1.1M
$1.3M
Q1 24
$3.3M
$960.3K
Total Debt
DRCT
DRCT
ICCC
ICCC
Q4 25
Q3 25
$10.8M
$9.5M
Q2 25
$33.5M
Q1 25
$32.9M
$8.7M
Q4 24
$9.0M
Q3 24
$150.0K
$9.4M
Q2 24
$34.8M
$9.8M
Q1 24
$32.4M
$10.2M
Stockholders' Equity
DRCT
DRCT
ICCC
ICCC
Q4 25
$-7.0M
Q3 25
$-6.7M
$29.8M
Q2 25
$-24.6M
$29.9M
Q1 25
$-23.3M
$29.0M
Q4 24
$-19.7M
$27.5M
Q3 24
$-16.7M
$26.4M
Q2 24
$-10.5M
$23.5M
Q1 24
$-7.5M
$24.6M
Total Assets
DRCT
DRCT
ICCC
ICCC
Q4 25
$20.2M
Q3 25
$22.5M
$45.7M
Q2 25
$23.3M
$46.7M
Q1 25
$23.8M
$45.6M
Q4 24
$26.0M
$45.1M
Q3 24
$31.3M
$44.4M
Q2 24
$48.5M
$41.9M
Q1 24
$52.8M
$43.1M
Debt / Equity
DRCT
DRCT
ICCC
ICCC
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DRCT
DRCT
ICCC
ICCC
Operating Cash FlowLast quarter
$-1.9M
$-1.2M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-32.3%
Capex IntensityCapex / Revenue
10.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DRCT
DRCT
ICCC
ICCC
Q4 25
$-1.9M
Q3 25
$-1.6M
$-1.2M
Q2 25
$-2.7M
$1.6M
Q1 25
$-2.7M
$1.6M
Q4 24
$-1.6M
$-3.1K
Q3 24
$3.0M
$-639.3K
Q2 24
$-4.4M
$581.8K
Q1 24
$-5.7M
$418.5K
Free Cash Flow
DRCT
DRCT
ICCC
ICCC
Q4 25
Q3 25
$-1.8M
Q2 25
$1.4M
Q1 25
$1.2M
Q4 24
$-199.3K
Q3 24
$-727.7K
Q2 24
$471.0K
Q1 24
$348.1K
FCF Margin
DRCT
DRCT
ICCC
ICCC
Q4 25
Q3 25
-32.3%
Q2 25
22.4%
Q1 25
15.4%
Q4 24
-2.6%
Q3 24
-12.1%
Q2 24
8.6%
Q1 24
4.8%
Capex Intensity
DRCT
DRCT
ICCC
ICCC
Q4 25
Q3 25
10.8%
Q2 25
2.4%
Q1 25
4.1%
Q4 24
2.5%
Q3 24
1.5%
Q2 24
2.0%
Q1 24
1.0%
Cash Conversion
DRCT
DRCT
ICCC
ICCC
Q4 25
Q3 25
Q2 25
3.19×
Q1 25
1.09×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DRCT
DRCT

Buy Side Advertising$8.2M98%
Other$183.0K2%

ICCC
ICCC

Segment breakdown not available.

Related Comparisons